Study of Zenith® t-Branch and Terumo Arch Branch for Aortic Aneurysms
This study is evaluating two types of special devices, the Zenith® t-Branch and the Terumo Arch Branch, for treating aortic aneurysms (bulges in the main artery of your body). The Zenith® t-Branch is a graft with branches to maintain blood flow to important organs, and the Terumo Arch Branch is a custom-made graft for specific problems in the upper part of the aorta. We are looking for people aged 18 and older with certain types of aortic aneurysms, including those that are large or have grown quickly. The main goals are to see how many people experience early death or stroke within 30 days after the device is implanted. So far, 186 people have received the Zenith® t-Branch and one has received the Arch Branch, and we are still enrolling participants.
- Study design
- This interventional study aims to enroll 235 participants. It is evaluating two different devices for treating aortic aneurysms.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed to measure early mortality and stroke at 30 days after the device is implanted.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- W. Anthony Lee, MD · PRINCIPAL_INVESTIGATOR · Lynn Heart and Vascular Institute, Boca Raton Regional Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Early Mortality & Stroke30 days post implant of the branch endografts
The primary aim of this study is to determine the rate of early mortality and stroke after branch endograft treatment.